SC
PFE icon

Sapient Capital’s Pfizer PFE Stock Holding History

Sapient Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$775K Sell
27,179
-399,889
-94% -$10.6M 0.01% 221
2026
Q2 		$10.3M Sell
427,068
-24,770
-5% -$648K 0.13% 82
2026
Q1 		$12.7M Sell
451,838
-22,939
-5% -$611K 0.19% 75
2025
Q4 		$11.9M Sell
474,777
-10,439
-2% -$263K 0.17% 84
2025
Q3 		$11.6M Sell
485,216
-21,658
-4% -$535K 0.18% 82
2025
Q2 		$12.3M Sell
506,874
-9,735
-2% -$227K 0.22% 74
2025
Q1 		$13.1M Sell
516,609
-3,236
-0.6% -$84.7K 0.26% 71
2024
Q4 		$13.8M Sell
519,845
-447,066
-46% -$12.1M 0.26% 69
2024
Q3 		$28M Buy
966,911
+13,879
+1% +$405K 0.56% 41
2024
Q2 		$26.7M Buy
953,032
+6,334
+0.7% +$174K 0.56% 38
2024
Q1 		$26.3M Buy
946,698
+890,095
+1,573% +$24.7M 0.58% 39
2023
Q4 		$1.63M Buy
+56,603
New +$1.71M 0.04% 138

Other funds holding PFE

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
WF
WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

Sapient Capital's PFE Position: Q3 2026 in Review

Sapient Capital reduced its Pfizer (PFE) stake by 94% in Q3 2026, selling an estimated $10.6M and leaving 27,179 shares worth $775K. The position accounts for 0.01% of the portfolio, ranked #221.

Sapient Capital first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $28M in Q3 2024. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Sapient Capital held 27,179 shares of Pfizer worth $775K as of Q3 2026.
  • Sapient Capital sold 399,889 Pfizer shares in Q3 2026, an estimated $10.6M.
  • Pfizer made up 0.01% of Sapient Capital's portfolio in Q3 2026, its #221 holding.
  • Sapient Capital first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
  • Sapient Capital's Pfizer position peaked at $28M in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Sapient Capital's 13F filing for Q3 2026, filed 8 Oct 2026.